Sabra Health Care REIT Q3 revenue rises year-over-year

Overview

• US healthcare REIT's Q3 revenue rose year-over-year, driven by higher resident fees and rental income

• Q3 net income increased year-over-year

• Same property SHOP Cash NOI grew 14.6% year-over-year in Q3

Outlook

• Sabra raises 2026 net income guidance to $0.265-$0.275 per share

• Company sees 2026 normalized FFO at $1.540-$1.550 per share

• Company expects mid-teens Cash NOI growth for same store SHOP in 2026

Result Drivers

• SHOP PORTFOLIO - Co said same property SHOP Cash NOI grew 14.6% year-over-year in Q3

• ACQUISITIONS - Co said Q3 results benefited from acquisition of SHOP communities and other investments

• PROPERTY TRANSITIONS - Co said transition of 26 properties led to higher annualized cash rent

Company press release:

Key Details

Analyst Coverage

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", 10 "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the specialized reits peer group is "buy"

• Wall Street's median 12-month price target for Sabra Health Care REIT, Inc. is $22.00, about 11.4% above its October 30 closing price of $19.74

• The stock recently traded at 28 times the next 12-month earnings vs. a P/E of 29 three months ago

Reuters Recommended Reads

• Nov 2 - IDEXX Laboratories Q3 revenue beats estimates, lifts FY profit outlook

• Nov 2 - IDEXX raises forecast, betting diagnostics can offset weak vet visits

• Nov 2 - Marriott tops Q3 revenue, profit estimates

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)